Acceptability of a Microbiome-directed Food in Young Children With Acute Malnutrition
- Conditions
- Malnutrition, Child
- Interventions
- Dietary Supplement: RUTF/RUSF then MDFDietary Supplement: MDF then RUTF/RUSF
- Registration Number
- NCT05551819
- Lead Sponsor
- Epicentre
- Brief Summary
This study will compare the acceptability a microbiome-directed food (MDF) with standard formulations of therapeutic/supplementary foods for the treatment of acute malnutrition using a 2 x 2 crossover design.
- Detailed Description
A randomized controlled trial will be conducted to assess the effectiveness of a microbiome-directed food (MDF) for treatment of uncomplicated acute malnutrition among children 6 to \<24 months of age in Niger. MDF will be compared to standard ready-to-use therapeutic foods (RUTF) for children with severe acute malnutrition (SAM) and to standard ready-to-use supplementary foods (RUSF) for children with moderate acute malnutrition (MAM). The acceptability and utilization of MDF will be assessed in this preliminary acceptability study before the proposed effectiveness trial. The results of this preliminary acceptability study will be used to inform expectations of MDF use during the subsequent randomized effectiveness trial.
Children aged 6 to \< 24 months will be eligible for enrollment in the acceptability trial on the day of their admission for treatment of uncomplicated severe or moderate acute malnutrition. Participants will be purposively selected to ensure balance by child age (6-11 vs 12 to \< 24 months) and sex. Recruitment will occur continuously (e.g. without sampling on consecutive working days) among all eligible children at 2 study health centers until the target sample size is achieved.
After providing written informed consent, children will be randomized to 1 of 2 feeding orders (MDF vs RUTF/RUSF). Children will be randomized and provided with one product for the first two weeks then crossover to consume the second product for a second two weeks.
At each follow up visit, study nurses will ask caregivers rate their child's liking of the supplement on a 5-point Likert scale, as well as record child weight and any morbidity or adverse event since last visit before dispensing the next supply of food. Caregivers will also be asked to describe at-home utilization, including the food consumed by the child, current eating patterns in relation to other household foods (e.g. use at mealtimes, as a complete replacement, replacement of specific food items), sharing or selling practices in the home and willingness to use the supplement in the future.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 274
- Are eligible for outpatient treatment of severe or moderate acute malnutrition according to the national protocol
- Are between 6 and <24 months of age
- Reside in the study catchment area and will remain there for at least 1 month
- Have no known allergy or contraindication to study product or standard treatment ingredients
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Feeding Order 2 RUTF/RUSF then MDF RUTF/RUSF then MDF Feeding Order 1 MDF then RUTF/RUSF MDF then RUTF/RUSF
- Primary Outcome Measures
Name Time Method Acceptability of at-home ration 2 weeks Consumption of 75% or more of the supplement provided during each 2-week period, where consumption is defined as total amount of food provided minus the total amount of food returned unused divided by the total amount of food provided.
Acceptability of test dose 30 minutes Consumption of 75% or more of the test dose within 30 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Guidan Roumji Health District
🇳🇪Guidan Roumji, Niger
Madarounfa Health District
🇳🇪Madarounfa, Niger